Introduction
Atherosclerosis - Overview
Atherosclerosis - Therapeutics Development
Atherosclerosis - Therapeutics Assessment
Atherosclerosis - Companies Involved in Therapeutics Development
Atherosclerosis - Drug Profiles
Atherosclerosis - Dormant Projects
Atherosclerosis - Discontinued Products
Atherosclerosis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Atherosclerosis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Companies, H1 2020 (Contd..3), H1 2020
Products under Development by Universities/Institutes, H1 2020
Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Target, H1 2020 (Contd..2), H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Atherosclerosis - Pipeline by 13therapeutics Inc, H1 2020
Atherosclerosis - Pipeline by Abcentra LLC, H1 2020
Atherosclerosis - Pipeline by ABIONYX Pharma SA, H1 2020
Atherosclerosis - Pipeline by AdaptVac ApS, H1 2020
Atherosclerosis - Pipeline by AFFiRiS AG, H1 2020
Atherosclerosis - Pipeline by Allysta Pharmaceuticals Inc, H1 2020
Atherosclerosis - Pipeline by Amgen Inc, H1 2020
Atherosclerosis - Pipeline by Annexin Pharmaceuticals AB, H1 2020
Atherosclerosis - Pipeline by AptaBio Therapeutics Inc, H1 2020
Atherosclerosis - Pipeline by Artery Therapeutics Inc, H1 2020
Atherosclerosis - Pipeline by Asdera LLC, H1 2020
Atherosclerosis - Pipeline by AstraZeneca Plc, H1 2020
Atherosclerosis - Pipeline by Athera Biotechnologies AB, H1 2020
Atherosclerosis - Pipeline by Auxagen Inc, H1 2020
Atherosclerosis - Pipeline by Band Therapeutics LLC, H1 2020
Atherosclerosis - Pipeline by BBN Cardio Therapeutics, H1 2020
Atherosclerosis - Pipeline by Boehringer Ingelheim International GmbH, H1 2020
Atherosclerosis - Pipeline by Centeer BioTherapeutics Ltd Co, H1 2020
Atherosclerosis - Pipeline by CohBar Inc, H1 2020
Atherosclerosis - Pipeline by Corbus Pharmaceuticals Inc, H1 2020
Atherosclerosis - Pipeline by General Regeneratives Shanghai Ltd, H1 2020
Atherosclerosis - Pipeline by GenKyoTex SA, H1 2020
Atherosclerosis - Pipeline by Grindeks AS, H1 2020
Atherosclerosis - Pipeline by Innolife Co Ltd, H1 2020
Atherosclerosis - Pipeline by Inotrem SA, H1 2020
Atherosclerosis - Pipeline by Inspyr Therapeutics Inc, H1 2020
Atherosclerosis - Pipeline by Iproteos SL, H1 2020
Atherosclerosis - Pipeline by Jenrin Discovery Inc, H1 2020
Atherosclerosis - Pipeline by Kaleido Biosciences Inc, H1 2020
Atherosclerosis - Pipeline by KineMed Inc, H1 2020
Atherosclerosis - Pipeline by Kowa Co Ltd, H1 2020
Atherosclerosis - Pipeline by LG Chem Ltd, H1 2020
Atherosclerosis - Pipeline by LipimetiX Development Inc, H1 2020
Atherosclerosis - Pipeline by MetiMedi Pharmaceuticals Co Ltd, H1 2020
Atherosclerosis - Pipeline by Mperia Therapeutics Inc, H1 2020
Atherosclerosis - Pipeline by Novartis AG, H1 2020
Atherosclerosis - Pipeline by NuSirt Biopharma Inc, H1 2020
Atherosclerosis - Pipeline by Omeros Corp, H1 2020
Atherosclerosis - Pipeline by Pharmahungary Group, H1 2020
Atherosclerosis - Pipeline by Regeneron Pharmaceuticals Inc, H1 2020
Atherosclerosis - Pipeline by Repair Biotechnologies Inc, H1 2020
Atherosclerosis - Pipeline by Riparian Pharmaceuticals Inc, H1 2020
Atherosclerosis - Pipeline by Sansho Co Ltd, H1 2020
Atherosclerosis - Pipeline by Serene LLC, H1 2020
Atherosclerosis - Pipeline by Shin Poong Pharm Co Ltd, H1 2020
Atherosclerosis - Pipeline by Signablok Inc, H1 2020
Atherosclerosis - Pipeline by Tiara Pharmaceuticals Inc, H1 2020
Atherosclerosis - Pipeline by Underdog Pharmaceuticals Inc, H1 2020
Atherosclerosis - Pipeline by Vascular Biogenics Ltd, H1 2020
Atherosclerosis - Pipeline by VasThera Research Institute, H1 2020
Atherosclerosis - Pipeline by Vaxil Bio Therapeutics Ltd, H1 2020
Atherosclerosis - Pipeline by Vicore Pharma AB, H1 2020
Atherosclerosis - Pipeline by Wooridul Pharmaceutical Ltd, H1 2020
Atherosclerosis - Pipeline by XBiotech Inc, H1 2020
Atherosclerosis - Dormant Projects, H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..1), H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..2), H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..3), H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..4), H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..5), H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..6), H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..7), H1 2020
Atherosclerosis - Dormant Projects, H1 2020 (Contd..8), H1 2020
Atherosclerosis - Discontinued Products, H1 2020
Atherosclerosis - Discontinued Products, H1 2020 (Contd..1), H1 2020
Atherosclerosis - Discontinued Products, H1 2020 (Contd..2), H1 2020

List of Figures
Number of Products under Development for Atherosclerosis, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• 13therapeutics Inc
• Abcentra LLC
• ABIONYX Pharma SA
• AdaptVac ApS
• AFFiRiS AG
• Allysta Pharmaceuticals Inc
• Amgen Inc
• Annexin Pharmaceuticals AB
• AptaBio Therapeutics Inc
• Artery Therapeutics Inc
• Asdera LLC
• AstraZeneca Plc
• Athera Biotechnologies AB
• Auxagen Inc
• Band Therapeutics LLC
• BBN Cardio Therapeutics
• Boehringer Ingelheim International GmbH
• Centeer BioTherapeutics Ltd Co
• CohBar Inc
• Corbus Pharmaceuticals Inc
• General Regeneratives Shanghai Ltd
• GenKyoTex SA
• Grindeks AS
• Innolife Co Ltd
• Inotrem SA
• Inspyr Therapeutics Inc
• Iproteos SL
• Jenrin Discovery Inc
• Kaleido Biosciences Inc
• KineMed Inc
• Kowa Co Ltd
• LG Chem Ltd
• LipimetiX Development Inc
• MetiMedi Pharmaceuticals Co Ltd
• Mperia Therapeutics Inc
• Novartis AG
• NuSirt Biopharma Inc
• Omeros Corp
• Pharmahungary Group
• Regeneron Pharmaceuticals Inc
• Repair Biotechnologies Inc
• Riparian Pharmaceuticals Inc
• Sansho Co Ltd
• Serene LLC
• Shin Poong Pharm Co Ltd
• Signablok Inc
• Tiara Pharmaceuticals Inc
• Underdog Pharmaceuticals Inc
• Vascular Biogenics Ltd
• VasThera Research Institute
• Vaxil Bio Therapeutics Ltd
• Vicore Pharma AB
• Wooridul Pharmaceutical Ltd
• XBiotech Inc